Hysadrac

Losartan potassium and hydrochlorothiazide, the active ingredients in Hysadrac, are an angiotensin II receptor blocker and a thiazide diuretic presented as oral tablets for adult use. They treat hypertension by lowering blood pressure in patients who require combined therapy.

GNH USA supplies Hysadrac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hysadrac combines an ARB and a thiazide diuretic to manage conditions within the cardiovascular and renal disease spectrum.

Hypertension: reduces systolic and diastolic pressure in primary hypertension. Diabetic nephropathy: helps slow progression of kidney damage in type 2 diabetes. Heart failure: used as adjunct therapy to control fluid overload and blood pressure in chronic heart failure.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urination - Mild electrolyte disturbances (e.g., low potassium) - Dry mouth or mild gastrointestinal upset

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Hyperkalemia or marked potassium loss - Angioedema or swelling of the face, lips, or throat - Acute kidney injury or significant rise in serum creatinine - Severe hypotension leading to fainting - Allergic skin reactions such as rash or Stevens‑Johnson syndrome

Before initiating therapy, consider the following precautions.

Monitor blood pressure regularly: ensure target levels are achieved without excessive drops. Check serum electrolytes: especially potassium and sodium, at baseline and during treatment. Assess renal function: evaluate creatinine and eGFR before and after starting. Avoid use in severe hepatic impairment: dose adjustments may be required. Pregnancy and lactation: use only if clearly needed, as safety data are limited. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Hysadrac may interact with several medicines; review patient medication lists.

Major Interactions (Avoid): - ACE inhibitors or aliskiren: risk of additive renal dysfunction and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - Lithium: increased lithium levels leading to toxicity. - NSAIDs: can blunt antihypertensive effect and impair renal function. - Cyclosporine or tacrolimus: heightened risk of nephrotoxicity.

Moderate Interactions (Monitor Closely): - Other antihypertensives (beta‑blockers, calcium channel blockers): may cause excessive blood pressure lowering. - Diuretics with similar electrolyte effects: monitor potassium and sodium. - CYP2C9 inhibitors (e.g., fluconazole): may increase losartan levels. - Antacids containing aluminum or magnesium: may reduce hydrochlorothiazide absorption.